Memorial Sloan-Kettering’s multidisciplinary team collaborates on each patient’s treatment from the very beginning. Medical oncologist David Ilson discusses a case.
Memorial Sloan-Kettering is home to more than 30 doctors and nurses who specialize exclusively in caring for people with esophageal cancer. Dedicated surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists, radiologists, and pathologists work together closely to develop every patient’s treatment plan. We meet regularly to discuss individual patients and the latest advances in treatment.
This team approach is particularly important in the treatment of esophageal cancer, because it is often best managed using a combination of chemotherapy, radiation therapy, and surgery. Having representatives of many different disciplines involved in your care ensures that all possible approaches to your treatment will be considered, and that your care will be well coordinated and personalized to your specific needs.
Every year 1.4 million people around the world are diagnosed with esophageal cancer, the majority of whom are from South America and China. David Ilson, a medical oncologist who specializes in esophageal cancer at Memorial Sloan-Kettering Cancer Center, provides an overview of the disease, and discusses treatment options and clinical trials for people at any stage of esophageal cancer.
Memorial Sloan-Kettering’s approach to diagnosing and treating esophageal cancer draws on the latest research breakthroughs and advances in clinical medicine.
In addition, Memorial Sloan-Kettering’s patient care program is complemented by our extensive esophageal cancer research effort. Our doctors are lead investigators in clinical trials to test new therapies and diagnostic methods for esophageal cancer. This means that choosing Memorial Sloan-Kettering for your care may enable you to gain access to new, experimental treatments and diagnostic approaches that are not widely available at other hospitals.